The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1197
December 6, 2004
View Complete Issue         Table of Contents 2019 
Dangerous Drugs
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Dangerous Drugs
December 6, 2004 (Issue: 1197)
At a US Senate hearing prompted by the withdrawal of Vioxx, an FDA officer cited 5 drugs as potentially dangerous. It may be useful to revisit Medical Letter reviews of these drugs.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Dangerous Drugs
Article code: 1197a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.